Literature DB >> 12614307

Overview: initial and long-term management of gastro-oesophageal reflux disease.

J Dent1, N J Talley.   

Abstract

Initial management of gastro-oesophageal reflux disease aims to confirm a symptom-based diagnosis, to relieve symptoms, to reassure the patient as to the treatable nature of reflux disease, and to initiate risk management and healing of oesophagitis. The aims of long-term management include adequate control of symptoms, prevention of complications, and improvement of quality of life. Management options in terms of use of proton pump inhibitors are either daily therapy (maintenance), intermittent courses of therapy (for example, 4 weeks, then cease and observe), or on-demand therapy. This overview discusses the advantages and disadvantages of these different strategies for the management of reflux disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614307     DOI: 10.1046/j.1365-2036.17.s1.10.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  Treatment of uncomplicated reflux disease.

Authors:  Joachim Labenz; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

2.  Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.

Authors:  Chih-Yen Chen; Ching-Liang Lu; Jiing-Chyuan Luo; Full-Young Chang; Shou-Dong Lee; Yung-Ling Lai
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

3.  A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD.

Authors:  Laura Bojke; Edward Hornby; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction.

Authors:  Julio Ponce; Lidia Argüello; Guillermo Bastida; Marta Ponce; Vicente Ortiz; Vicente Garrigues
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

5.  Maintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg.

Authors:  D G Morgan; M F J O'Mahony; W F O'Mahony; J Roy; F Camacho; J Dinniwell; G L A Horbay; F A Husein-Bhabha
Journal:  Can J Gastroenterol       Date:  2007-12       Impact factor: 3.522

6.  Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial.

Authors:  Hung-Hsien Chiang; Deng-Chyang Wu; Pin-I Hsu; Chao-Hung Kuo; Wei-Chen Tai; Shih-Cheng Yang; Keng-Liang Wu; Chih-Chien Yao; Cheng-En Tsai; Chih-Ming Liang; Yao-Kuang Wang; Jiunn-Wei Wang; Chih-Fang Huang; Seng-Kee Chuah
Journal:  Drug Des Devel Ther       Date:  2019-04-26       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.